Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: A nested case-control study

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1626-1635

  Rebecca , E James ^a   Lukanova, Annekatrin ^a   Dossus, Laure ^a   Becker, Susen ^b   Rinaldi, Sabina ^c   Tjønneland, Anne ^d   Olsen, Anja ^d   Overvad, Kim ^e   Mesrine, Sylvie ^f,g   Engel, Pierre ^f,g   Clavel Chapelon, Françoise ^f,g   Chang Claude, Jenny ^a   Vrieling, Alina ^a   Boeing, Heiner ^h   Schütze, Madlen ^h   Trichopoulou, Antonia ^i,j   Lagiou, Pagona ^i,l   Trichopoulos, Dimitrios ^k,l   Palli, Domenico ^m   Krogh, Vittorio ⁿ   Panico, Salvatore ^o   Tumino, Rosario ^p   Sacerdote, Carlotta ^q   Rodríguez, Laudina ^r   Buckland, Genevieve ^s   Sánchez, Maria José ^t   Amiano, Pilar ^u   Ardanaz, Eva ^v,w   Bueno de Mesquita, Bas ^x   Ros, Martine M ^x   Van Gils, Carla H ^y   Peeters, Petra H ^y   Khaw, Kay Tee ^z   Wareham, Nick ^aa   Key, Timothy J ^ab   Allen, Naomi E ^ab   Romieu, Isabelle ^c   Siddiq, Afshan ^ac   Cox, David ^ac   Riboli, Elio ^ac   Kaaks, Rudolf ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j HELLENIC HEALTH FOUNDATION   (Greece)

^k BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^p CIVILE M P AREZZO HOSPITAL   (Italy)

^q HuGeF Foundation and CPO Piemonte   (Italy)

^r Health and Health Care Services Council   (Spain)

^s Unit of Nutrition Environment and Cancer   (Spain)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 80053912279     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0090     Document Type: Article

References (44)

1. Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2009;6:718-30.
2. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558-68. (Pubitemid 39331875)
3. Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol 2007;25:4772-8. (Pubitemid 350086480)
4. Geyer FC, Reis-Filho JS. Microarray-base gene expression profiling as a clinical tool for breast cancer management: Are we there yet? Int J Surg Pathol 2008;17:285-302.
5. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
6. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008;10:R65.
7. Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, et al. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:2482-8. (Pubitemid 46048309)
8. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 2001;92:37-45. (Pubitemid 32623038)
9. Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16. (Pubitemid 34498648)
10. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82. (Pubitemid 41815798)
11. Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, et al. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1995;4:857-60.
12. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cancer Epidemiol Biomarkers Prev 2005;14:1047-51. (Pubitemid 40656446)
13. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:492-502.
14. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65. (Pubitemid 40081323)
15. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009;18:169-76.
16. Riboli E, Kaaks R. The EPIC project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26 Suppl 1:S6-14.
17. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
18. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81. (Pubitemid 29220854)
19. McCann J. Better assays needed for hormone receptor status, experts say. J Natl Cancer Inst 2001;93:579-80. (Pubitemid 32409622)
20. Layfield LJ, Gupta D, Mooney EE. Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods. Breast J 2000;6:189-96. (Pubitemid 30347116)
21. Flowers JL, Burton GV, Cox EB, McCarty KS Sr, Dent GA, Geisinger KR, et al. Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies. Ann Surg 1986;203:250-4. (Pubitemid 16011287)
22. Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection ER-ICA) in breast cancer tissue]. Pathologe 1987;8:138-40.
23. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72. (Pubitemid 30645223)
24. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065-71. (Pubitemid 35192658)
25. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-13. (Pubitemid 36749764)
26. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index?Psychol Methods 2006;11:193-206. (Pubitemid 44001277)
27. Kahan Z, Gardi J, Nyari T, Foldesi I, Hajnal-Papp R, Ormandi K, et al. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Int J Oncol 2006;29:193-200.
28. von WR, Mengel M, Wiese B, Rudiger T, Muller-Hermelink HK, Kreipe H. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002;118:675-82.
29. Speroff L. Postmenopausal hormone therapy and breast cancer: a clinician's message for patients. Endocrine 2004;24:211-6. (Pubitemid 41271151)
30. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010;95:s1-66.
31. Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, Dossus L, et al. Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 2006;118:2832-9. (Pubitemid 43673364)
32. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40. (Pubitemid 33585924)
33. Hankinson SE. Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 2005;24:3-15.
34. Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005;23:1616-22. (Pubitemid 46211414)
35. Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000;27:135-45.
36. Duffy MJ, O'Donovan N, Crown J. Use of molecular markers for predicting therapy response in cancer patients. Cancer Treat Rev 2011;37:151-9.
37. Allred DC, Brown P, Medina D. The origins of estrogen receptor alphapositive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 2004;6:240-5. (Pubitemid 39440252)
38. Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003;24:152-82. (Pubitemid 36515283)
39. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, et al. Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 2005;12:701-20. (Pubitemid 41815772)
40. Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N, et al. Androgens in human breast carcinoma. Med Mol Morphol 2010;43:75-81.
41. Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F. Androgen receptor is frequently expressed in HER2-positive, ER/ PR-negative breast cancers. Virchows Arch 2010;457:467-76.
42. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 2006;25:3994-4008. (Pubitemid 43990755)
43. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
44. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-15. (Pubitemid 44530717)